SC
HTGM

Samjo Capital’s HTG Molecular Diagnostics, Inc. Common Stock HTGM Stock Holding History

Samjo Capital’s Portfolio HTGM Stock Details HTGM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-33,747
Closed -$563K – 21
2022
Q1 		$563K Sell
33,747
-15,420
-31% -$495K 0.48% 19
2021
Q4 		$3.2M Sell
49,167
-5,833
-11% -$340K 2.14% 12
2021
Q3 		$3.77M Buy
55,000
+10,500
+24% +$751K 2.77% 13
2021
Q2 		$3.1M Buy
44,500
+8,667
+24% +$469K 2.1% 14
2021
Q1 		$2.35M Buy
35,833
+4,024
+13% +$305K 1.74% 15
2020
Q4 		$1.83M Buy
+31,809
New +$1.85M 1.56% 12

Other funds holding HTGM

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Samjo Capital's HTGM Position: Q2 2022 in Review

Samjo Capital sold out of HTG Molecular Diagnostics, Inc. Common Stock (HTGM) in Q2 2022, closing a stake of 33,747 shares — an estimated $563K sold.

Samjo Capital first reported a position in HTGM in Q4 2020 and held it in 6 quarters. The position peaked at $3.77M in Q3 2021. 21 funds tracked by Wall St. Rank hold HTGM as of Q2 2022.

  • Samjo Capital reported no remaining HTG Molecular Diagnostics, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Samjo Capital sold 33,747 HTG Molecular Diagnostics, Inc. Common Stock shares in Q2 2022, an estimated $563K.
  • Samjo Capital first reported a position in HTG Molecular Diagnostics, Inc. Common Stock in Q4 2020 and held it in 6 quarters.
  • Samjo Capital's HTG Molecular Diagnostics, Inc. Common Stock position peaked at $3.77M in Q3 2021.
  • 21 funds tracked by Wall St. Rank held HTG Molecular Diagnostics, Inc. Common Stock as of Q2 2022.

Based on Samjo Capital's 13F filing for Q2 2022, filed 4 Aug 2022.